BRINEURA
Google image searchProduct monograph
Active ingredient
cerliponase alfa, 150 MG/5 ML
DIN: 02484013
Dosage form(s): SOLUTION
Route(s) of administration: INTRACEREBROVENTRICULAR
Schedule: Prescription / Schedule D
Company: BIOMARIN INTERNATIONAL LIMITED
Date: 18-MAR-2019
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AB — Enzymes (ATC, ATC/DDD)
- A16AB17 — CERLIPONASE ALFA (ATC/DDD)
Reference brand drug: Brineura
Pharmaceutical standard: MFR
